Joki et al. [8] have reported that treatment with a COX-2 inhibitor, NS-398, reduced tumor cell migration and proliferation and increased apoptosis in mice bearing xenografts of U-87MG and U-251MG glioma cell lines. This evidence concerns the gene PTGS2 and glioma.